TEVA PHARMACEUTICAL INDUSTRIES LIMITED Derivative Asset
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) had Derivative Asset of $8.00 million as of 2023-12-31, per its 10-Q filed 2024-11-06.
Financial Statements › Balance Sheet › Assets
us-gaap:DerivativeAssets · last filed 2024-11-06
- 2023-12-31: Derivative Asset $8.00M.
| Period end | Derivative Asset |
|---|---|
| 2023-12-31 | $8.00M 10-Q · filed 2024-11-06 |